glp-1 impact on bariatric surgery Medication vs. for Weight Loss: Options Matter The GLP-1 Struggle: Daily Fatigue

Gomez-Lechon, M

Ahrn B (2001) Inhibition of dipeptidyl peptidase-4 (DPP-4): a target to treat type 2 diabetes

Chu H, Lin Z, Zhong L, Mccallum RW, Hou X

Background: Dementia, Alzheimers & Type 3 Diabetes Dementiaespecially Alzheimers disease (AD)is a progressive decline in cognition, memory, planning, and daily functioning

[DOI] [PMC free article] [PubMed] [Google Scholar] 55.Grieco M., Giorgi A., Gentile M.C., dErme M., Morano S., Maras B., Filardi T

Previous analyses placed sygl-1 and lst-1 downstream of, or parallel to, GLP-1/Notch signaling and upstream of GLD differentiation regulators, but their relationship with FBF was unresolved [18, 25] (Fig 1B)